Atherogenic lipid phenotype in a general group of subjects

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 11, 2007, Pages 1679-1685

  Van, Joanne ^a   Pan, Jianqiu ^a,b   Charles, M Arthur ^a,e   Krauss, Ronald ^c   Wong, Nathan ^d   Wu, Xiaoshan ^a  

^a University Clinical Investigators Inc   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; DYSLIPIDEMIA; FEMALE; HISTOGRAM; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PARTICLE SIZE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DETERMINATION; REFERENCE VALUE; SEX DIFFERENCE; ULTRACENTRIFUGATION;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; PILOT PROJECTS; REFERENCE VALUES; RISK FACTORS;

EID: 35948961048     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bernies K, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002;43:1363-1379.
2. Charles MA, Nguyen C. Atherogenic lipid phenotype and lipoprotein (a) in diabetes. Endocrinologist. 2002;18:1203-1243.
3. Lamarche B, Tchernof A, Moorjani A, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of Ischemic heart disease in men. Circulation. 1997;95:69-75.
4. Griffin BA, Freeman DJ, Graeme WT, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
5. Tan CE, Caslake MJ, Bedford D, et al. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscl Thromb Vasc Biol. 1995;15:1839-1848.
6. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. Arterioscl Thromb. 1991;11:174-182.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel of detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2488-2497.
8. Austin MA, Mykkänen L, Kuusisto J, et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation. 1995;92:1770-1776.
9. Pan J, Lin M, Kesala R, Van JT, Charles MA. Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes. Diabetes Obes Metab. 2002;4:1-17.
10. Van JT, Pan J, Wasty T, Chan E, Wu X, Charles MA. Extended release niacin and atorvastation monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus. Am J Cardiol. 2002;89:1306-1308.
11. Pan J, Van JT, Chan E, Kesala R, Lin M, Charles MA. Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein (a) in diabetes. Metabolism. 2002;51:1120-1127.
12. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 1993;92:141-146.
13. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993;88:381-387.
14. Packard CJ, Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscl Thromb Vasc Biol. 1997;17:3542-3556.
15. Zambon A, Hukanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation. 1999;99:1959-1964.
16. Krauss RM, Blanche PJ. Detection and quantitation of LDL subfractions. Curr Opin Lipidol. 1992;3:377-383.
17. Dreon DM, Fernstrom HA, Williams PT, Krauss RM. LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. Arterioscl Thromb Vasc Biol. 1997;17:707-714.
18. Krauss RM, Burke D. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
19. Guerin M, Lassel TS, Goff WL, Farnier M, Chapman J. Action of atorvastatin in combined hyperlipidemia: preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Arterioscl Thromb Vasc Biol. 2000;20:189-197.
20. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
21. Miller BD, Alderman EL, Haskell WM, Fair JM, Krauss RM. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford coronary risk intervention project. Circulation. 1996;94:2146-2153.
22. Geiss HC, Otto C, Schwandt P, Parhofer K. Effect of Atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects. Metabolism. 2001;50:983-988.
23. Caixas A, Ordonez-Llanos J, de Leiva A, Payes A, Homs R, Perez A. Optimization of glycemic control by insulin therapy decreases the proportion of small, dense LDL particles in diabetic patients. Diabetes. 1997;46:1207-1213.
24. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention or coronary disease. N Engl J Med. 2001;345:1583-1592.
25. Freedman DS, Bowman BA, Srinivasan SR, et al. Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism. 2001;50:370-376.
26. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S adults. Diabetes Care. 2004;27:2444-2449.
27. Yang X, Hsu-Hage B, Zhang H, et al. Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care. 2002;25:847-852.
28. Ferrara A, Hedderson M, Quesenberry C, Selby J. Prevalence of gestational diabetes mellitus detected by the National Diabetes Data Group or the Carpenter and Couston plasma glucose thresholds. Diabetes Care. 2002;25:1625-1630.